Sensei Biotherapeutics Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 24 institutions reported holding Sensei Biotherapeutics Inc. in their 13F filings, down 1 from Q1 2024. 5 opened new positions and 6 sold out. The largest holders were Ikarian Capital, LLC ($403K), Vanguard Group Inc. ($384K) and Renaissance Technologies ($139K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sensei Biotherapeutics Inc.
- CUSIP
- 81728A108
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $536K |
| Exits | 6 | $1.0M |
All 13F filers, Q1 2024 → Q2 2024: 950,649 shares bought and 1,152,258 shares sold, net −201,609 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Ikarian Capital, LLC | 0.13% | New | 650,000 | $403K |
| Vanguard Group Inc. | 0.00% | Add +7.8% | 618,757 | $384K |
| Renaissance Technologies | 0.00% | Add +6.1% | 223,785 | $139K |
| Boothbay Fund Management, LLC | 0.00% | New | 172,835 | $107K |
| Geode Capital Management, LLC | 0.00% | Add +19.7% | 163,139 | $101K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -31.0% | 77,900 | $48K |
| Northern Trust Corp. | 0.00% | Reduce -0.3% | 25,983 | $16K |
| State Street Corp. | 0.00% | No change | 25,774 | $16K |
| Cresset Asset Management, LLC | 0.00% | No change | 19,671 | $12K |
| Two Sigma Securities, LLC | 0.00% | New | 18,600 | $12K |
| Citadel Advisors | 0.00% | Reduce -35.6% | 15,366 | $10K |
| Leo Wealth, LLC | 0.00% | No change | 14,845 | $9K |
| XTX Topco Ltd | 0.00% | New | 14,047 | $9K |
| Raymond James & Associates | 0.00% | No change | 14,000 | $9K |
| Morgan Stanley | 0.00% | No change | 12,219 | $8K |
| Deuterium Capital Management, LLC | 0.01% | No change | 11,000 | $7K |
| National Bank of Canada | 0.00% | New | 10,000 | $6K |
| BlackRock Inc. | 0.00% | Reduce -76.8% | 7,777 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +5.6% | 7,087 | $4K |
| Banque Cantonale Vaudoise | 0.00% | No change | 3,900 | $2K |
| JPMorgan Chase & Co. | 0.00% | Add +12.0% | 748 | $464 |
| Bank of America Corp. | 0.00% | Reduce -99.8% | 139 | $86 |
| Qube Research & Technologies Ltd | 0.00% | No change | 4 | $2 |
| Royal Bank of Canada | 0.00% | Add +366.0% | 247 | $0 |
"% of holder's portfolio" is SENSEI BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Sensei Biotherapeutics Inc. the manager owns.